BeOne Medicines (ONC) Gross Profit Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.76% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 16.94% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 2,488.21% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 41.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.37% |
| Dec 31, 2025 | 40.16% |
| Sep 30, 2025 | 46.28% |
| Jun 30, 2025 | 45.47% |
| Mar 31, 2025 | 51.95% |
| Dec 31, 2024 | 82.99% |
| Sep 30, 2024 | 21.33% |
| Jun 30, 2024 | 58.44% |
| Mar 31, 2024 | 71.23% |
| Dec 31, 2023 | 72.41% |
| Sep 30, 2023 | 120.20% |
| Jun 30, 2023 | 84.64% |
| Mar 31, 2023 | 51.63% |
| Dec 31, 2022 | 85.31% |
| Sep 30, 2022 | 95.62% |
| Jun 30, 2022 | 137.76% |
| Mar 31, 2022 | -57.89% |
| Dec 31, 2021 | 109.35% |
| Sep 30, 2021 | 127.32% |
| Jun 30, 2021 | 121.57% |
| Mar 31, 2021 | 1,411.97% |
| Dec 31, 2020 | 103.10% |
| Sep 30, 2020 | 132.92% |
| Jun 30, 2020 | -61.16% |
| Mar 31, 2020 | -39.41% |
| Dec 31, 2019 | -21.36% |
| Sep 30, 2019 | -33.98% |
| Jun 30, 2019 | 183.92% |
| Mar 31, 2019 | 123.52% |
| Dec 31, 2018 | 226.71% |
| Sep 30, 2018 | -79.16% |